Loading...
Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT
OBJECTIVES: Preclinical and clinical studies suggested cardioprotective effects of metformin treatment. In the GIPS-III trial, 4 months of metformin treatment did not improve left ventricular ejection fraction in patients presenting with ST-elevation myocardial infarction (STEMI). Here, we report th...
Na minha lista:
| Udgivet i: | Clin Res Cardiol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5696505/ https://ncbi.nlm.nih.gov/pubmed/28755285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00392-017-1140-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|